Martínez-Cuadrón, David; Megias-Vericat, Juan-E; Gil, Cristina; Bernal, Teresa; Tormo, Mar; Martínez-Sánchez, Pilar; Rodríguez-Medina, Carlos; Serrano, Josefina; Herrera, Pilar; Pérez-Simón, José-Antonio; Sayas, María-José; Bergua, Juan; Lavilla-Rubira, Esperanza; Amigo, María-Luz; Benavente, Celina; López-orenzo, José-L; Pérez-Encinas, Manuel-Mateo; Vidriales, María-B; Colorado, Mercedes; de-Rueda, Beatriz; García-Boyero, Raimundo; Marini, Sandra; García-Suárez, Julio; López-Pavia, María; Gómez-Roncero, María-I; Noriega, Víctor; López, Aurelio; Labrador, Jorge; Cabello, Ana; Sossa, Claudia; Algarra, Lorenzo; Stevenazzi, Mariana; Solana-Altabella, Antonio; Boluda, Blanca; Montesinos, Pau
(FERRATA STORTI FOUNDATION, 2024-01)
Treatment options for patients with secondary acute myeloid leukemia (sAML) and AML with myeloid-related changes (AMLMRC) aged 60 to 75 years are scarce and unsuitable. A pivotal trial showed that CPX-351 improved complete ...